Superior quality cytokines are crucial for reliable research results and the safe production of cancer cell therapies.

Adenosine deaminase 2 (ADA2) has been identified as a regulator of toll-like receptor 9 (TLR9) activation in response to nucleic acids, according to a recent study.

For decades, depression has been ascribed to chemical deficiencies in the brain. New evidence suggests inflammation may cause ...

Autoimmune responses are not the same as a healthy immune system working to counteract a foreign biological invader. Yet the ...

Mayo Clinic researchers have identified interleukin-23 receptor (IL-23R) as a significant biomarker of cellular senescence ...

The eyes have long been regarded as "immune-privileged" organs. Immunological system of ocular tissues prevents or resolves ...

A research team led by Professor Kelvin Yeung Wai-kwok from the Department of Orthopaedics and Traumatology, School of ...

Six CAR-T-cell therapies have been approved by the European Commission and the US FDA, and other T-cell therapies are being ...

The global natural killer cells therapeutics market size was US$ 2,808.9 million in 2021. The global natural killer cells therapeutics market size is forecast to reach US$ 10,213.5 million by 2030, ...